InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 23.99 M

InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 23.99 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 39.96% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 17.14 M, a 42.79% change year over year.
  • InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 12.00 M, a 12.61% change year over year.
  • InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 10.66 M, a 18.20% change year over year.
  • InspireMD, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 9.02 M, a 20.58% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue